Focal therapy for localized prostate cancer with high-intensity focused ultrasound
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000023242
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
We treated 90 men (median age: 70 years; median PSA level: 7.26 ng/ml). Catheterization was performed within 24 hours after the treatment in all patients. Biochemical disease-free rate was 92.2% during 21 months follow-up when use of Phoenix ASTRO definition. In follow-up biopsy, significant cancer was detected in 8.9% of the patients in un-treated areas. Urinary functions were preserved preoperative levels at 3 or 6 months. Rates of ED and ejaculation who had the functions were 86% and 70%, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who have anal stenosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Oncological outcomes 2. Urinary continence, erectile dysfunction
- Secondary Outcome Measures
Name Time Method